MORGAN BAKER: Open Payments
NPI 1609400886 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 11 payments from 9 companies in 2025. Trend: 2023 $331 · 2024 $641 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $64 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| ABIOMED | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Veozah, INSPIRE, REXULTI, QULIPTA, TRELEGY ELLIPTA, OPSUMIT, JARDIANCE, Ozempic.
Industry payments across GA — which companies pay providers there.
